National Comprehensive Cancer Network

About NCCN

NCCN’s 2nd Annual Global Corporate Council Meeting Discusses Concerns in Cancer Care on a Global Scale and NCCN’s Efforts to Respond

By Caitlin Donnelly, Business Insights Specialist, NCCN

The 2nd Annual National Comprehensive Cancer Network® (NCCN®) Global Corporate Council Meeting took place in Hollywood, Florida in conjunction with the NCCN 21st Annual Conference: Advancing the Standard of Cancer Care™.  The meeting brought together industry leaders for a discussion of current topics of interest in global oncology.  Speakers included NCCN staff members as well as regionally-focused oncology specialists.   

C. Lyn Fitzgerald, MJ, Senior Vice President, U.S. & Global Development, NCCN, began the meeting by welcoming the NCCN Global Corporate Council attendees and giving a broad introduction to NCCN.  She also introduced the day’s first speaker, Corey Casper, MD, MPH, Head of Global Oncology and Full Member, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Dr. Casper spoke of the current state of cancer care in sub-Saharan Africa and his work with the Uganda Cancer Institute/Hutchinson Center Cancer Alliance.  He discussed the Alliance’s endeavor to establish a quality cancer research and treatment center in Uganda, as well as their work training Ugandan medical staff in the United States to run the facility.

Robert W. Carlson, MD, Chief Executive Officer, NCCN, gave an update on NCCN and elaborated on its current global Initiatives, including translations and adaptations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and outreach to various global organizations, such as the Union for International Cancer Control (UICC), of which NCCN is a member.  Dr. Carlson also elaborated on the NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework™), NCCN’s initiative to address disparity in resource levels.

André P. Fay, MD, PhD, Professor of Medicine at PUCRS School of Medicine, and Visiting Scientist at Dana- Farber Cancer Institute followed Dr. Carlson.  Dr. Fay, who is a member of the Latin American Cooperative Oncology Group (LACOG), began by discussing cancer care in Latin America and the growing discrepancy between public and private health care. He also talked about LACOG’s partnership with NCCN to create regional adaptations of the NCCN Guidelines® for Prostate Cancer. Dr. Fay closed his presentation by discussing a need for increased clinical trials in Latin America to offset the lack of access to necessary care.

Marisa Cavalieri, Director, U.S. & Global Business Insights, NCCN, closed the meeting with a call to action for our Global Corporate Council Members, emphasizing the need for the translation of NCCN Guidelines and other NCCN Content so that they might be more accessible on a global scale.

For additional information regarding NCCN Global Corporate Council, please contact Caitlin Donnelly, Business Insight Specialist, NCCN:  For information about NCCN’s Global initiatives, please contact Jorge Bacigalupo, Global Business Development Specialist, NCCN: